Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Messina

Showing results (41-50 of 162) with videos related to

Pageof 17
Sort By:
Neuromuscular Disorders : NMD|January 22, 2004
Pilot trial of phenylbutyrate in spinal muscular atrophyEugenio Mercuri, Enrico Bertini, Sonia Messina, et al.
Neuromuscular Disorders : NMD|November 27, 2004
Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutationsHeinz Jungbluth, Mark R Davis, Clemens Müller, et al.
Neuromuscular Disorders : NMD|April 20, 2020
Screening for early symptoms of respiratory involvement in myotonic dystrophy type 1 using the Respicheck questionnaireElisa De Mattia, Andrea Lizio, Elisa Falcier, et al.
Neuromuscular Disorders : NMD|December 4, 2019
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophySonia Messina, Anna Lia Frongia, Laura Antonaci, et al.
Annals of Neurology|March 13, 2010
Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spineEugenio Mercuri, Emma Clements, Amaka Offiah, et al.
Neuromuscular Disorders : NMD|June 27, 2008
Daily salbutamol in young patients with SMA type IIMarika Pane, Susanna Staccioli, Sonia Messina, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 26, 2020
Which are the factors influencing NIV adaptation and tolerance in ALS patients?Massimo Russo, Carmen Bonanno, Claudia Profazio, et al.
European Journal of Human Genetics : EJHG|July 16, 2009
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCRFrancesco Danilo Tiziano, Anna Maria Pinto, Stefania Fiori, et al.
Neurology|August 28, 2019
Long-term progression in type II spinal muscular atrophy: A retrospective observational studyEugenio Mercuri, Simona Lucibello, Maria Carmela Pera, et al.
Brain Sciences|January 20, 2021
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular DystrophyGian Luca Vita, Maria Sframeli, Norma Licata, et al.
Pageof 17

Showing results (41-50 of 162) with videos related to

Sort By:
Pageof 17
Neuromuscular Disorders : NMD|January 22, 2004
Pilot trial of phenylbutyrate in spinal muscular atrophyEugenio Mercuri, Enrico Bertini, Sonia Messina, et al.
Neuromuscular Disorders : NMD|November 27, 2004
Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutationsHeinz Jungbluth, Mark R Davis, Clemens Müller, et al.
Neuromuscular Disorders : NMD|April 20, 2020
Screening for early symptoms of respiratory involvement in myotonic dystrophy type 1 using the Respicheck questionnaireElisa De Mattia, Andrea Lizio, Elisa Falcier, et al.
Neuromuscular Disorders : NMD|December 4, 2019
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophySonia Messina, Anna Lia Frongia, Laura Antonaci, et al.
Annals of Neurology|March 13, 2010
Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spineEugenio Mercuri, Emma Clements, Amaka Offiah, et al.
Neuromuscular Disorders : NMD|June 27, 2008
Daily salbutamol in young patients with SMA type IIMarika Pane, Susanna Staccioli, Sonia Messina, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 26, 2020
Which are the factors influencing NIV adaptation and tolerance in ALS patients?Massimo Russo, Carmen Bonanno, Claudia Profazio, et al.
European Journal of Human Genetics : EJHG|July 16, 2009
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCRFrancesco Danilo Tiziano, Anna Maria Pinto, Stefania Fiori, et al.
Neurology|August 28, 2019
Long-term progression in type II spinal muscular atrophy: A retrospective observational studyEugenio Mercuri, Simona Lucibello, Maria Carmela Pera, et al.
Brain Sciences|January 20, 2021
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular DystrophyGian Luca Vita, Maria Sframeli, Norma Licata, et al.
Pageof 17